Clinical Trial Update: A Study to Assess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic Patients [Phase 3]

View source ↗

Summary

The document reports the completion of a Phase 3 study evaluating ASP1941 in combination with a DPP-4 inhibitor for Type 2 Diabetes Mellitus, focusing on safety…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• ASP1941

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED